SS Innovations International (NASDAQ: SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences

What happened

SS Innovations International said its SSi Mantra surgical robot and SSi MantrAsana remote console were used in successful telesurgeries at two international medical conferences in October 2026, including a cardiac procedure performed from Barcelona on a patient about 7,500 miles away in India.

Confirmed

Global impact / market context

If remote robotic surgery works reliably, hospitals could offer specialist care across long distances, which may support demand for SS Innovations' systems and consoles. Wider adoption would depend on surgeon training, regulatory approval and hospital budgets for new equipment.

Analyst inference

The company is presenting conference demonstrations as evidence of real-world use. Investors may treat the reported 205 telesurgeries as a sign of growing clinical experience, while weighing that conference showcases do not by themselves prove broad commercial adoption or recurring revenue.

Analyst inference

What to watch

1. As of October 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system, according to the company. Confirmed
2. Watch whether hospitals announce purchases or paid clinical programs using the SSi Mantra and SSi MantrAsana console, which would show demand beyond conference demonstrations. Proposed
3. Track regulatory clearances and surgeon training in new markets, because remote surgery requires approvals and skilled operators before hospitals can adopt it at scale. Analyst inference

Evidence

• financewire.com